~~<i id='BF85C4C10C'><strike id='BF85C4C10C'><tt id='BF85C4C10C'><pre id='BF85C4C10C'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：Wikipedia 2025-08-23 01:42:42 Page View：169

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare wants to send $9 billion to 340B hospitals
Next article： Wildfire smoke exposes gaps in outdoor worker protections

focus

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Biden targets hefty hospital 'facility fees' that often surprise patients

AdobeAspartoftheBidenadministration’sbroadereffortstolowerhealthcarecosts,theWhiteHouseannouncednewg

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Ahead of JPM, here's who's profiting most in health care

AdobeForalltheflaktheyget,thecountry’sfourbiggestpharmacybenefitmanagersreportedasurprisinglytameave

WSS

leisure time

leisure time

explore

focus

Ahead of JPM, here's who's profiting most in health care